The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Related Party Transaction

10 Mar 2022 07:00

RNS Number : 2721E
Maven Income and Growth VCT 5 PLC
10 March 2022
 

MAVEN INCOME AND GROWTH VCT 5 PLC

LEI: 213800DMF84841RMWX35

9 March 2022

Related Party Transaction

 

Maven Income and Growth VCT 5 PLC (the "Company") announces that, following a review and taking into account peer group analysis, the Company's administrative and secretarial fee and performance fee arrangements with the Company's investment manager, Maven Capital Partners UK LLP ("Maven"), have changed.

 

With effect from 1 December 2021, the annual administrative and secretarial fee payable to Maven will be increased from £86,000, to £100,000, payable quarterly in arrears and subject to an annual adjustment, calculated on 1 December each year.

 

Maven will continue to be entitled to a performance fee on a revised basis with effect from 1 December 2021 should certain criteria be met. The updated key terms of the calculation of the performance fee are summarised below:

§ the performance fee in respect of private equity investments has been increased to 15 per cent.; and

§ the performance fee in respect of the Company's quoted portfolio is now payable on all quoted investments (excluding any investment trusts).

Maven has agreed to decrease the cap on the total expenses payable by the Company from 3.25 per cent. to 3.0 per cent. of the Company's net assets per annum, adjusted annually and excluding performance fees and exceptional costs.

 

Under the Listing Rules of the FCA, a related party includes the investment manager of a closed-ended investment fund. Maven is therefore a related party of the Company under the Listing Rules and the increase in the fees payable by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

 

The Board's agreement to change the administrative and secretarial fee and the performance fee payable to Maven is a smaller related party transaction as defined in LR11.1.10R.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

 

9 March 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKCBPDBKBFNK
Date   Source Headline
15th Mar 201311:59 amRNSNet Asset Value(s)
14th Mar 201310:37 amRNSNet Asset Value(s)
13th Mar 20132:27 pmRNSReplacement re Issue of Equity
13th Mar 201311:25 amRNSNet Asset Value(s)
12th Mar 20134:56 pmRNSForm 8.3 - [FFastFill PLC]
12th Mar 201311:05 amRNSNet Asset Value(s)
11th Mar 201311:30 amRNSNet Asset Value(s)
8th Mar 201311:26 amRNSNet Asset Value(s)
7th Mar 20132:29 pmRNSNet Asset Value(s)
6th Mar 201311:14 amRNSNet Asset Value(s)
5th Mar 20134:15 pmRNSIssue of Equity
5th Mar 20132:32 pmRNSNet Asset Value(s)
5th Mar 20137:00 amRNSChange of Adviser
4th Mar 201310:50 amRNSNet Asset Value(s)
1st Mar 201311:34 amRNSNet Asset Value(s)
28th Feb 201310:24 amRNSNet Asset Value(s)
27th Feb 201312:31 pmRNSNet Asset Value(s)
26th Feb 201312:46 pmRNSNet Asset Value(s)
25th Feb 201312:21 pmRNSNet Asset Value(s)
22nd Feb 201312:15 pmRNSNet Asset Value(s)
21st Feb 20132:41 pmRNSNet Asset Value(s)
20th Feb 201311:51 amRNSNet Asset Value(s)
19th Feb 201312:26 pmRNSNet Asset Value(s)
18th Feb 201310:38 amRNSNet Asset Value(s)
15th Feb 201311:30 amRNSNet Asset Value(s)
14th Feb 201310:11 amRNSNet Asset Value(s)
13th Feb 201311:48 amRNSNet Asset Value(s)
12th Feb 201311:04 amRNSNet Asset Value(s)
11th Feb 20135:41 pmRNSOffer for Subscription - Update
11th Feb 20135:40 pmRNSOffer for Subscription - Update
11th Feb 201312:24 pmRNSNet Asset Value(s)
8th Feb 20134:38 pmRNSNet Asset Value(s)
7th Feb 201312:48 pmRNSNet Asset Value(s)
6th Feb 201312:56 pmRNSNet Asset Value(s)
5th Feb 201312:42 pmRNSNet Asset Value(s)
4th Feb 20132:06 pmRNSTransaction in Own Shares
4th Feb 201311:45 amRNSNet Asset Value(s)
1st Feb 20132:43 pmRNSTransaction in Own Shares
1st Feb 201312:02 pmRNSNet Asset Value(s)
31st Jan 20132:46 pmRNSTransaction in Own Shares
31st Jan 20132:02 pmRNSNet Asset Value(s)
30th Jan 20133:41 pmRNSTransaction in Own Shares
30th Jan 201312:40 pmRNSNet Asset Value(s)
29th Jan 20135:10 pmRNSTransaction in Own Shares
29th Jan 201312:15 pmRNSNet Asset Value(s)
28th Jan 20135:08 pmRNSTransaction in Own Shares
28th Jan 201312:46 pmRNSNet Asset Value(s)
25th Jan 20132:55 pmRNSTransaction in Own Shares
25th Jan 201312:20 pmRNSNet Asset Value(s)
24th Jan 201311:51 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.